Brainstorm Cell Therapeutics | BCLI - Equity Capital And Reserves


Brainstorm Cell Therapeutics reported $-9.98M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Biogen USD 18.65B 394.9M Mar/2026
Brainstorm Cell Therapeutics USD -9.98M 2.29M Dec/2025
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 102.73M 58.9M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Cytokinetics USD -826.57M 166.94M Mar/2026
Gilead Sciences USD 22.62B 1.16B Dec/2025
Grifols EUR 6.21B 133.12M Dec/2025
Halozyme Therapeutics USD 48.81M 455.1M Dec/2025
Mesoblast USD 574.68M 22.76M Dec/2025